ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
FDA Grants Accelerated Approval Of Avastin In Combination With Paclitaxel Chemotherapy For Treatment Of Advanced HER2-Negative Breast Cancer
Genentech, Inc. (NYSE:DNA) announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for Avastin® (bevacizumab), in combination with paclitaxel chemotherapy, for the treatment of patients who have not received chemotherapy for their metastatic HER2-negative breast cancer. The approval is based on a Phase III study (E2100) that showed that Avastin in combination with paclitaxel chemotherapy resulted in a 52 percent reduction in the risk of disease progression or death compared to those treated with paclitaxel alone and a doubling in progression-free survival (PFS) (based on a hazard ratio of 0.48; p
Granturi aprobarea FDA accelerat de Avastin în asociere cu paclitaxel pentru tratamentul de chimioterapie a avansat HER2-negative cancer de sân - FDA Grants Accelerated Approval Of Avastin In Combination With Paclitaxel Chemotherapy For Treatment Of Advanced HER2-Negative Breast Cancer - articole medicale engleza - startsanatate
